Atwood & Palmer’s GSK GSK Stock Holding History

Atwood & Palmer’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50	Closed	-$3K	–	452
2021 Q4	$3K	Buy	+50	New	+$2.6K	﹤0.01%	422
2016 Q2	–	Sell	-800	Closed	-$41K	–	309
2016 Q1	$41K	Hold	800	–	–	0.01%	186
2015 Q4	$40K	Hold	800	–	–	0.01%	215
2015 Q3	$38K	Hold	800	–	–	0.01%	211
2015 Q2	$42K	Hold	800	–	–	0.01%	196
2015 Q1	$46K	Hold	800	–	–	0.01%	188
2014 Q4	$43K	Hold	800	–	–	0.01%	203
2014 Q3	$46K	Sell	800 -80	-9%	-$4.9K	0.01%	209
2014 Q2	$59K	Buy	+880	New	+$59.6K	0.02%	181

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Atwood & Palmer's GSK Position: Q1 2022 in Review

Atwood & Palmer sold out of GSK (GSK) in Q1 2022, closing a stake of 50 shares — an estimated $3K sold.

Atwood & Palmer first reported a position in GSK in Q2 2014 and held it in 9 quarters. The position peaked at $59K in Q2 2014. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

Atwood & Palmer reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
Atwood & Palmer sold 50 GSK shares in Q1 2022, an estimated $3K.
Atwood & Palmer first reported a position in GSK in Q2 2014 and held it in 9 quarters.
Atwood & Palmer's GSK position peaked at $59K in Q2 2014.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Atwood & Palmer's 13F filing for Q1 2022, filed 29 Apr 2022.